Category: Latest

Latest financial and market news — updated throughout the day on EarnFree.in

NTPC Q1 ResultNET PROFIT 45.10B RUPEES VS 40.7B (YOY)REVENUE 444.19B RUPEES VS 391.22B (YOY)EBITDA 124.46B RUPEES VS 113.69B (YOY)EBITDA MARGIN 28.02% VS 29.06% (YOY) #StockMarket #FinancialNews #Trading https://earnfree.in/ NTPC Q1 ResultNET PROFIT 45.10B RUPEES VS 40.7B (YOY)REVENUE 444.19B RUPEES VS 391.22B (YOY)EBITDA 124.46B RUPEES VS 113.69B (YOY)EBITDA MARGIN 28.02% VS 29.06% (YOY) #StockMarket #FinancialNews #Trading https://earnfree.in/

NTPC Q1 Result NET PROFIT 45.10B RUPEES VS 40.7B (YOY) REVENUE 444.19B RUPEES VS 391.22B (YOY) EBITDA 124.46B RUPEES VS 113.69B (YOY) EBITDA MARGIN 28.02% […]

HINDUSTAN ZINC: CO SAYS GOT TAX ORDER FOR DEMAND OF 18.84B RUPEES || CO HAS FILED RECTIFICATION APPLICATION BEFORE TAX AUTHORITY #StockMarket #FinancialNews #Trading HINDUSTAN ZINC: CO SAYS GOT TAX ORDER FOR DEMAND OF 18.84B RUPEES || CO HAS FILED RECTIFICATION APPLICATION BEFORE TAX AUTHORITY #StockMarket #FinancialNews #Trading

HINDUSTAN ZINC: CO SAYS GOT TAX ORDER FOR DEMAND OF 18.84B RUPEES || CO HAS FILED RECTIFICATION APPLICATION BEFORE TAX AUTHORITY #StockMarket #FinancialNews #Trading HINDUSTAN […]

‌IDBI BIG NEWSINDIAN GOVT TO ALLOW POTENTIAL BIDDERS TO ACCESS IDBI BANK’S PRIVATE DATA IN EARLY AUGUST – DIVESTMENT SECRETARY: RBI HAS INDICATED COMPLETION OF ITS “FIT AND PROPER” VETTING OF POTENTIAL BIDDERS OF CO – DIVESTMENT SECRETARY #StockMarket #FinancialNews #Trading ‌IDBI BIG NEWSINDIAN GOVT TO ALLOW POTENTIAL BIDDERS TO ACCESS IDBI BANK’S PRIVATE DATA IN EARLY AUGUST – DIVESTMENT SECRETARY: RBI HAS INDICATED COMPLETION OF ITS “FIT AND PROPER” VETTING OF POTENTIAL BIDDERS OF CO – DIVESTMENT SECRETARY #StockMarket #FinancialNews #Trading

‌IDBI BIG NEWS INDIAN GOVT TO ALLOW POTENTIAL BIDDERS TO ACCESS IDBI BANK'S PRIVATE DATA IN EARLY AUGUST – DIVESTMENT SECRETARY : RBI HAS INDICATED […]

Market@ noon Nifty up by 240 points (+0.90%) Top Gainers : ADANIENSOL +4.65%, SBILIFE +4.13% Top Losers : UNITDSPR -1.65%, ONGC -1.04% #StockMarket #FinancialNews #Trading Market@ noon Nifty up by 240 points (+0.90%) Top Gainers : ADANIENSOL +4.65%, SBILIFE +4.13% Top Losers : UNITDSPR -1.65%, ONGC -1.04% #StockMarket #FinancialNews #Trading

Market@ noonNifty up by 240 points (+0.90%) Top Gainers : ADANIENSOL +4.65%, SBILIFE +4.13% Top Losers : UNITDSPR -1.65%, ONGC -1.04% #StockMarket #FinancialNews #Trading Market@ […]

Market Alert | Nifty metal up over 3% led by Adani Ent , Vedanta; registers biggest single session gain in 1 monthNifty crosses 24,800 mark; less than 50 points away from record high #StockMarket #FinancialNews #Trading Market Alert | Nifty metal up over 3% led by Adani Ent , Vedanta; registers biggest single session gain in 1 monthNifty crosses 24,800 mark; less than 50 points away from record high #StockMarket #FinancialNews #Trading

Market Alert | Nifty metal up over 3% led by Adani Ent , Vedanta; registers biggest single session gain in 1 month Nifty crosses 24,800 […]

ALEMBIC PHARMA: CO SAYS GMP INSPECTION AT PANELAV FACILITY WAS SUCCESSFULLY COMPLETED WITHOUT ANY FORM 483 OBSERVATION #StockMarket #FinancialNews #Trading ALEMBIC PHARMA: CO SAYS GMP INSPECTION AT PANELAV FACILITY WAS SUCCESSFULLY COMPLETED WITHOUT ANY FORM 483 OBSERVATION #StockMarket #FinancialNews #Trading

ALEMBIC PHARMA: CO SAYS GMP INSPECTION AT PANELAV FACILITY WAS SUCCESSFULLY COMPLETED WITHOUT ANY FORM 483 OBSERVATION #StockMarket #FinancialNews #Trading ALEMBIC PHARMA: CO SAYS GMP […]

#SUNPHARMA: received approval from the U.S. Food and Drug Administration (FDA) for LEQSELVI (deuruxolitinib) 8 mg tablets for the treatment of adults with severe alopecia areata. #StockMarket #FinancialNews #Trading #SUNPHARMA: received approval from the U.S. Food and Drug Administration (FDA) for LEQSELVI (deuruxolitinib) 8 mg tablets for the treatment of adults with severe alopecia areata. #StockMarket #FinancialNews #Trading

#SUNPHARMA: received approval from the U.S. Food and Drug Administration (FDA) for LEQSELVI (deuruxolitinib) 8 mg tablets for the treatment of adults with severe alopecia […]